Risk of Acute Myocardial Infarction in Pneumoconiosis: Results from a Retrospective Cohort Study. 2023

Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
Graduate Institute of Clinical Medicine Science, China Medical University, No. 91, Xue-Shi Road, Taichung 404, Taiwan.

BACKGROUND Pneumoconiosis (PCN) has several comorbidities, most notably pulmonary and cardiovascular diseases. However, much is still unknown about the relationship between PCN and acute myocardial infarction (AMI). The present study aimed to clarify the association between PCN and subsequent AMI risk using a retrospective cohort study design. METHODS This was a population-based, retrospective cohort study that used data from Taiwan's National Health Insurance Database. A total of 7556 newly diagnosed patients with PCN and 7556 individuals without PCN were included in the PCN and comparison cohort (PC and CC), respectively, between 2008 and 2018, with propensity score matching for age, gender, comorbidity, medication, and date of PCN diagnosis. The occurrence of AMI was monitored until the end of 2019, and AMI risk was assessed using Cox proportional hazard regression models. RESULTS The overall incidence of AMI was 1.34-fold higher in the PC than in the CC (4.33 vs. 3.23 per 1000 person-years, respectively, p < 0.05), with an adjusted hazard ratio (aHR) of 1.36 (95% confidence interval (CI): 1.08-1.72) after controlling for age, gender, comorbidity, and medication. Further analyses showed a higher risk of AMI with increased annual number of emergency department visits among patients with PCN (aHR: 1.30, 95% CI: 1.01-1.66 (<1) and aHR: 1.68, 95% CI: 1.13-2.50 (≥1)). CONCLUSIONS Patients with PCN had a significantly higher risk of developing AMI than those without PCN. Clinicians should pay more attention to prevent AMI episodes in patients with PCN.

UI MeSH Term Description Entries

Related Publications

Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
January 2023, Biomedicines,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
October 2013, International journal of cardiology,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
June 2015, The Journal of dermatological treatment,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
August 2004, International journal of impotence research,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
April 2019, BMC psychiatry,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
November 2021, Respiratory medicine,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
January 2013, Journal of cutaneous medicine and surgery,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
October 2021, BMJ open,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
April 2024, Journal of epidemiology and global health,
Ju-Hsin Chang, and Te-Chun Shen, and Ke-Wei Chen, and Cheng-Li Lin, and Chung Y Hsu, and Yeong-Ray Wen, and Kuan-Cheng Chang
July 2014, International journal of cardiology,
Copied contents to your clipboard!